Advanced search
Start date
Betweenand

Julia Alejandra Pezuk

CV Lattes GoogleMyCitations


Sociedade Beneficente de Senhoras (SBSHSL). Hospital Sírio-Libanês  (Institutional affiliation for the last research proposal)
Birthplace: Argentina

Argentinian-Brazilian researcher, graduated in Genetics by the Facultad de Ciencias Exactas, Químicas y Naturales- Universidad Nacional de Misiones, Argentina (2008), revalidated in Brazil as BA in Biological Sciences by the Universidade Federal do Rio Grande do Sul (2010). She has a master's degree and PhD in Biological Sciences (Area of concentration: Genetics) by the Genetics Department of the School of Medicine of Ribeirão Preto, University of São Paulo (2011 and 2014 respectively). She has a post-doctora experiencel in Health Science at the Instituto Sírio-Libanês de Ensino e Pesquisa of the Hospital Sírio-Libanês. She is currently coordinator and permanent PhD professor of the Stricto Sensu Graduate Program in Biotechnology and Innovation in Health, permanent PhD professor of the Pharmacy program and of the Science and Health Teaching program at the Anhanguera University of São Paulo (UNIAN/SP), is a full member of the Ethics Committee for Research with Human Beings at the same institution and participates in the structuring Teaching Nucleus of the Nursing course. Member of the Brazilian Society of Oncology Pharmacists. And he is a member of CONSUN. She has experience in Genetics, Evolution, Cellular and Molecular Biology, Biochemestry and Teaching. E-mail: julia.pezuk@hotmail.com (Source: Lattes Curriculum)

News published in Agência FAPESP Newsletter about the researcher
Articles published in other media outlets (0 total):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)
Scholarships in Brazil
FAPESP support in numbers * Updated December 04, 2021
Total / Available in English
3 / 3   Completed scholarships in Brazil

Associated processes
Most frequent collaborators in research granted by FAPESP
Contact researcher

Use this Research Supported by FAPESP (BV/FAPESP) channel only to send messages referring to FAPESP-funded scientific projects.


 

 

 

 

Keywords used by the researcher
Scientific publications resulting from Research Grants and Scholarships under the grantee's responsibility (6)

(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)

Publications6
Citations56
Cit./Article9.3
Data from Web of Science

PEZUK, JULIA ALEJANDRA; BRASSESCO, MARIA SOL; MANZINI RAMOS, PRISCILA MARIA; SCRIDELI, CARLOS ALBERTO; TONE, LUIZ GONZAGA. Polo-Like Kinase 1 Pharmacological Inhibition as Monotherapy or in Combination: Comparative Effects of Polo-Like Kinase 1 Inhibition in Medulloblastoma Cells. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, v. 17, n. 9, p. 1278-1291, . Web of Science Citations: 3. (11/11287-3, 11/01026-8)

PEZUK, JULIA ALEJANDRA; BRASSESCO, MARIA SOL; DE OLIVEIRA, RICARDO SANTOS; MACHADO, HELIO RUBENS; NEDER, LUCIANO; SCRIDELI, CARLOS ALBERTO; TONE, LUIZ GONZAGA. PLK1-associated microRNAs are correlated with pediatric medulloblastoma prognosis. CHILD'S NERVOUS SYSTEM, v. 33, n. 4, p. 609-615, . Web of Science Citations: 7. (11/11287-3, 11/01026-8)

PEZUK, JULIA ALEJANDRA; ARAUJO MILLER, THIAGO LUIZ; BARBOSA BEVILACQUA, JOSE LUIZ; SIMOES DORNELLAS DE BARROS, ALFREDO CARLOS; MARTINS DE ANDRADE, FELIPE EDUARDO; DE ANDRADE E MACEDO, LUIZA FREIRE; AGUILAR, VERA; MENARDO CLARO, AMANDA NATASHA; CAMARGO, ANAMARIA ARANHA; FAVORETTO GALANTE, PEDRO ALEXANDRE; et al. Measuring plasma levels of three microRNAs can improve the accuracy for identification of malignant breast lesions in women with BI-RADS 4 mammography. ONCOTARGET, v. 8, n. 48, p. 83940-83948, . Web of Science Citations: 5. (13/03107-0, 14/14025-8)

RAMOS, PRISCILA M. M.; PEZUK, JULIA A.; CASTRO-GAMERO, ANGEL M.; OLIVEIRA, HARLEY F.; SCRIDELI, CARLOS A.; UMEZAWA, KAZUO; TONE, LUIZ G.. Antineoplastic Effects of NF-kappa B Inhibition by DHMEQ (Dehydroxymethylepoxyquinomicin) Alone and in Co-treatment with Radio-and Chemotherapy in Medulloblastoma Cell Lines. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, v. 18, n. 4, p. 541-549, . Web of Science Citations: 3. (11/01026-8, 10/18792-2)

PEZUK, J. A.; BRASSESCO, M. S.; MORALES, A. G.; DE OLIVEIRA, J. C.; DE PAULA QUEIROZ, R. G.; MACHADO, H. R.; CARLOTTI, JR., C. G.; NEDER, L.; SCRIDELI, C. A.; TONE, L. G.. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma. Cancer Gene Therapy, v. 20, n. 9, p. 499-506, . Web of Science Citations: 26. (09/11053-2)

PEZUK, JULIA ALEJANDRA; BRASSESCO, MARIA SOL; MORALES, ANDRESSA GOIS; DE OLIVEIRA, JAQUELINE CARVALHO; DE OLIVEIRA, HARLEY FRANCISCO; SCRIDELI, CARLOS ALBERTO; TONE, LUIZ GONZAGA. Inhibition of Polo-Like Kinase 1 Induces Cell Cycle Arrest and Sensitizes Glioblastoma Cells to Ionizing Radiation. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, v. 28, n. 7, p. 516-522, . Web of Science Citations: 12. (09/11053-2)

Please report errors in researcher information by writing to: cdi@fapesp.br.
X

Report errors in this page


Error details: